华法林对感染性内心炎患者的死亡率,急性心力衰竭和感染分辨率风险的影响:一个目标试验仿真
Teddy Tai Loy Lee1,2, Chengsheng Ju3,4, Sunny Ching Long Chan1
1Department of Emergency Medicine, School of Clinical Medicine The University of Hong Kong Hong Kong China.
Journal of the American Heart Association
|July 17, 2025
概括
在感染性内心炎 (IE) 患者中使用华法林显著降低了死亡风险,并通过改善血液培养负面性来帮助感染解决. 然而,它不会增加急性心力衰竭的风险.
科学领域:
- 心脏病学 心脏病学
- 传染性疾病 传染性疾病
- 临床药理学 临床药理学
背景情况:
- 传染性内心炎 (IE) 由于急性心力衰竭和细菌血症等并发症而带来重大死亡风险.
- 在IE患者中使用华法林抗凝剂仍然是临床辩论的主题.
- 了解华法林对IE结果的影响对于患者管理至关重要.
研究的目的:
- 评估华法林抗凝剂对被诊断患有传染性内心炎的患者的存活率的影响.
- 评估华法林对减少血栓栓塞事件和可能缩短感染持续时间的影响.
- 分析华法林对IE全因死亡率,急性心力衰竭发病率和血液培养负面性的影响.
主要方法:
- 基于人口的回顾性队列研究,使用香港临床数据分析和报告系统.
- 在1997年1月1日至2020年8月31日期间,通过ICD-9代码识别IE患者.
- 使用克隆-审查-权衡实用试验的模拟,以比较华法林启动 (14天内) 与没有华法林,分析死亡率,心力衰竭和血液培养状态.
主要成果:
- 华法林使用与12周生存率增加6.5% (RR 0.72) 和阴性血培养率增加11.4% (RR 1.13) 相关.
- 华法林使用者与非使用者之间没有观察到急性心力衰竭风险的显著差异 (RR 1.07).
- 该研究包括5121名IE患者,平均年龄为55.7岁.
结论:
- 在IE患者中启用华法林与显著降低死亡风险有关.
- 华法林的使用可能在解决感染方面有好处,如血培养负性的改善所示.
- 该研究表明,华法林不会增加IE患者急性心力衰竭的风险.
相关概念视频
Endocarditis IV: Nursing Management
37
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
37
Endocarditis III: Medical Management
20
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
20
Endocarditis II: Clinical Features of Infective Endocarditis
28
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
28
Venous Thrombosis III: Interprofessional Care
25
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
25
Endocarditis I: Introduction
32
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
32
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K


